FrancophonIA/ELRC3.0 huggingface dataset:
English: Valtrex accelerates the resolution of pain: it reduces the duration of and the proportion of patients with zoster-associated pain, which includes acute and, in patients older than 50 years, also post-herpetic neuralgia.
Slovenian: Zdravilo Valtrex pospeši pojemanje in izginotje bolečine: skrajša trajanje bolečine in zmanjša delež bolnikov z bolečinami zaradi herpesa zostra, vključno z akutno in (pri bolnikih, starejših od 50 let) tudi postherpetično nevralgijo.
English: ≥1/100 to < 1/10,
Slovenian: ≥ 1/100 do < 1/10
English: What Valtrex is and what it is used for Before you take Valtrex How to take Valtrex Possible side effects How to store Valtrex Further information
Slovenian: Kaj je zdravilo Valtrex in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Valtrex Kako jemati zdravilo Valtrex Možni neželeni učinki
English: Pharmacokinetic data indicate that hepatic impairment decreases the rate of conversion of valaciclovir to aciclovir but not the extent of conversion.
Slovenian: Farmakokinetični podatki kažejo, da okvara jeter zmanjša hitrost pretvorbe valaciklovirja v aciklovir, ne zmanjša pa obsega te pretvorbe.
English: HSV Suppression in HIV-infected Patients
Slovenian: Supresija HSV pri bolnikih, okuženih s HIV
English: For the proposed valaciclovir dosage regimens, predicted total acyclovir AUCs for subjects with severe renal impairment are greater than those expected in subjects with less severe renal impairment.
Slovenian: Za predlagane režime odmerjanja valaciklovirja so napovedane skupne vrednosti AUC aciklovirja za osebe s hudo okvarjenim delovanjem ledvic večje od tistih, ki so pričakovane za osebe z manj okvarjenim delovanjem ledvic.
English: The CHMP proposed to reduce doses in renal impairment but the MAH was of the opinion that the precautionary statements regarding use in the elderly and patients with renal impairment, the maintenance of adequate hydration, and adherence to the recommended dosage reductions for patients with renal impairment were adequate and appropriate.
Slovenian: CHMP je predlagal zmanjšanje odmerkov pri bolnikih z okvaro ledvic, vendar je imetnik dovoljenja za promet z zdravilom menil, da so previdnostne izjave glede uporabe pri starostnikih in bolnikih z okvarjenim delovanjem ledvic, ohranjanja zadostne hidracije in upoštevanja priporočenih zmanjšanj odmerkov pri bolnikih z okvarjenim delovanjem ledvic zadostne in primerne.
English: Immunocompetent Adults
Slovenian: Imunokompetentni odrasli
English: Herpes labialis
Slovenian: Labialni herpes
English: Treatment and Suppression of HSV-Related Ocular Infections The MAH presented several studies to evaluate the efficacy of oral aciclovir for HSV keratitis after penetrating keratoplasty (Barney, 1994; van Rooij, 1995, 2003).
Slovenian: Zdravljenje in supresija očesnih okužb, povezanih s HSV Imetnik dovoljenja za promet z zdravilom je predložil več študij za presojo učinkovitosti peroralnega aciklovirja za zdravljenje keratitisa zaradi HSV po penetrantni keratoplastiki (Barney, 1994; van Rooij, 1995, 2003).
English: Dosage selection for treatment of cold sores was based on administration of high-dose valaciclovir during prodrome, targeting plasma concentrations to exceed the in vitro IC99, based on the hypothesis that optimal antiviral effect would be obtained from high systemic exposure during the time that viral replication dominates temporarily over the host immune response.
Slovenian: Izbira odmerka za zdravljenje herpesa na ustnici je temeljila na uporabi velikih odmerkov valaciklovirja v prodromalni fazi s ciljnimi koncentracijami v plazmi, ki presegajo in vitro vrednost IC99, na osnovi hipoteze, da se bo optimalni protivirusni učinek dosegel z visoko sistemsko izpostavljenostjo v času, ko razmnoževanje virusa začasno prevladuje nad imunskim odzivom gostitelja.
English: The MAH presented two studies in order to support the safety use of VACV (Study 123-016 and Study 123-039).
Slovenian: Imetnik dovoljenja za promet z zdravilom je v podporo varne uporabe VACV predložil dve študiji (študiji 123-016 in 123-039).
English: Hypersensitivity to valaciclovir or aciclovir or any of the excipients (see section 6.1).
Slovenian: Preobčutljivost za valaciklovir, aciklovir ali katerokoli pomožno snov (glejte poglavje 6.1).
English: The Ljungman study demonstrated that valaciclovir was significantly more effective than oral aciclovir in reducing the incidence of CMV infection (P <0.0001), and the safety of oral valaciclovir was similar to that of high-dose oral aciclovir.
Slovenian: V Ljungmanovi študiji so dokazali, da je valaciklovir znatno učinkovitejši od peroralnega aciklovirja pri zmanjšanju pojavnosti okužbe s CMV (p < 0,0001), varnost peroralnega valaciklovirja pa je bila podobna kot pri velikih peroralnih odmerkih aciklovirja.
English: A significant proportion of the congenital anomalies described in the articles were consistent with the known foetal adverse effects of intra-uterine infection with CMV.
Slovenian: Pomemben delež kongenitalnih nenormalnosti, ki so opisane v člankih, se ujema z znanimi neželenimi učinki na plod, ki so posledica intrauterine okužbe s CMV.
English: Thus, in addition to altered acyclovir pharmacokinetics in renal impairment, this factor also needs to be taken into account in developing dosage adjustments based on Cmax and/or AUC.
Slovenian: Zato je treba ta faktor upoštevati pri spremenjenih farmakokinetiki aciklovirja pri zmanjšanem delovanju ledvic in tudi pri razvoju prilagoditev odmerka na osnovi Cmax in/ali AUC.
English: Animal studies do not show reproductive toxicity for valaciclovir (see section 5.3).
Slovenian: Študije na živalih ne kažejo, da bi imel valaciklovir toksične učinke na sposobnost razmnoževanja (glejte poglavje 5.3).
English: The metabolite 8-OH-ACV is detected only in small amounts in urine (< 2% of the recovered dose).
Slovenian: Presnovka 8-OHACV je v urinu le malo (< 2 % odmerka, ki se pojavi v urinu).
English: Acyclovir bioavailability from valaciclovir decreases somewhat with increasing dose.
Slovenian: Biološka razpoložljivost aciklovirja iz valaciklovirja se nekoliko zmanjša s povečevanjem odmerka.
English: Regarding the prevention of ocular complications, present in some MS SPC, the CHMP noted that it is a secondary benefit of the treatment of VZV infection, therefore this part of the indication was covered by a statement in section 5.1.
Slovenian: V zvezi s preprečevanjem očesnih zapletov, ki so omenjeni v povzetkih glavnih značilnosti zdravila v določenih državah članicah, CHMP ugotavlja, da gre za sekundarno korist zdravljenja okužbe z VZV, zato ta del indikacije obravnava izjava v poglavju 5.1.
English: 50 to <75
Slovenian: 50 do < 75
English: Other uncommon side effects:
Slovenian: Drugi občasni neželeni učinki:
English: Use in CMV infections
Slovenian: Uporaba pri okužbah s CMV
English: If you are taking Valtrex to treat or prevent genital herpes, or you have had genital herpes in the past, you should still practice safe sex, including the use of condoms.
Slovenian: Preprečevanje prenosa genitalnega herpesa na druge Če jemljete zdravilo Valtrex za zdravljenje ali preprečevanje genitalnega herpesa, ali če ste imeli genitalni herpes kdaj v preteklosti, morate še vedno upoštevati ukrepe za varnejšo spolnost (vključno z uporabo kondomov).
English: Pharmacokinetic data in adult patients with advanced cirrhosis (impaired hepatic synthetic function and evidence of portal-systemic shunting) do not indicate the need for dose adjustment; however, clinical experience is limited.
Slovenian: Farmakokinetični podatki pri odraslih bolnikih z napredovalo cirozo (okvarjeno sintezno delovanje jeter in znaki portosistemskega obvoda) ne kažejo potrebe po prilagoditvi odmerka, toda kliničnih izkušenj je malo.
English: • unsteadiness when walking and lack of coordination (ataxia)
Slovenian: • negotovost pri hoji in pomanjkljiva koordinacija gibov (ataksija),
English: The CHMP considered Herpes labialis covered by the indication “Treatment and suppression of HSV infections of the skin and mucous membranes”, and concluded that does not deserve to be specified in section 4.1 of the SPC although the short course dosage shall be mentioned in Section 4.2.
Slovenian: CHMP je menil, da je labialni herpes obravnavan v indikaciji „Zdravljenje in supresija okužb s HSV na koži in sluznicah“ ter zaključil, da ne zasluži navedbe v poglavju 4.1 povzetka glavnih značilnosti zdravila, čeprav bo odmerjanje za kratki režim omenjeno v poglavju 4.2.
English: After oral administration valaciclovir is well absorbed and rapidly and almost completely converted to aciclovir and valine.
Slovenian: Po peroralni uporabi se valaciklovir dobro absorbira in se hitro ter skoraj popolnoma pretvori v aciklovir in valin.
English: A switch from IV aciclovir to oral antiviral therapy (to complete a 10-14 day treatment course) is reasonable when formation of new cutaneous lesions has ceased and the signs and symptoms of visceral VZV infection are improving [CDC, 2009].
Slovenian: aciklovirja na peroralno protivirusno zdravljenje (da bolnik opravi 10-14-dnevno zdravljenje) je smiseln, ko nove kožne lezije ne nastajajo več in se znaki in simptomi visceralne okužbe z VZV izboljšujejo [CDC, 2009].
English: The CHMP agreed a reduced dosage in renal impairment.
Slovenian: CHMP se je strinjal z zmanjšanim odmerjanjem pri okvari delovanja ledvic.
English: The MAH, as requested, included an introductory statement in Section 4.8 to clarify the sample size/exposure from clinical trials.
Slovenian: Imetnik dovoljenja za promet z zdravilom je v skladu z zahtevami v poglavje 4.8 vključil uvodno izjavo, da se pojasni velikost vzorca in izpostavljenost v kliničnih preskušanjih.
English: Section 4.1 Therapeutic Indications
Slovenian: Poglavje 4.1 Terapevtske indikacije
English: The CHMP concluded that the indication about prophylaxis for transmission of genital herpes with VACV can not be regarded to as indication itself but rather to be associated with the treatment of initial and recurrent treatment of genital herpes.
Slovenian: CHMP je menil, da se indikacija o profilaksi za prenos genitalnega herpesa z VACV ne more šteti kot samostojna indikacija, ampak se mora pridružiti začetnemu zdravljenju in zdravljenju ponavljajočega se genitalnega herpesa.
English: High dose valaciclovir as required for CMV prophylaxis may result in more frequent adverse events, including CNS abnormalities, than observed with lower doses administered for other indications (see section 4.8).
Slovenian: Veliki odmerki valaciklovirja, potrebni za profilakso CMV, lahko povzročijo pogostejše neželene učinke, vključno z nepravilnostmi osrednjega živčevja, kot pa so opazni z manjšimi odmerki, uporabljenimi za druge indikacije (glejte poglavje 4.8).
English: Accordingly, evaluation of valaciclovir dosage regimens for patients with renal impairment were primarily derived such that peak acyclovir concentrations (Cmax) would approximate those from 2000mg bid one-day dosing in subjects with CLcr from 50 to 120 mL/min.
Slovenian: V skladu s tem so bile presoje režimov odmerjanja valaciklovirja pri bolnikih z okvarjenim delovanjem ledvic primarno izpeljane tako, da naj bi se najvišje koncentracije aciklovirja (Cmax) približale tistim iz odmerjanja 2000 mg dvakrat dnevno en dan pri osebah s CLcr od 50 do 120 mL/min.
English: These findings have also been observed in patients not treated with valaciclovir who have the same underlying or concurrent conditions.
Slovenian: To so opažali tudi pri bolnikih, ki niso bili zdravljeni z valaciklovirjem in so imeli iste osnovne oz. spremljajoče bolezni ali motnje.
English: • for the treatment and suppression of HSV infections of the skin and mucous membranes including - treatment of first-episode of genital herpes in immunocompetent adults and adolescents and in immunocompromised adults - treatment of recurrences of genital herpes in immunocompetent adults and adolescents, and in immunocompromised adults - suppression of recurrent genital herpes in immunocompetent adults and adolescents and in immunocompromised adults
Slovenian: • za zdravljenje in supresijo okužb s HSV na koži in sluznicah, vključno z - zdravljenjem prve epizode genitalnega herpesa pri imunsko kompetentnih odraslih bolnikih in mladostnikih ter imunsko kompromitiranih odraslih bolnikih, - zdravljenjem ponovitev genitalnega herpesa pri imunsko kompetentnih odraslih bolnikih in mladostnikih ter imunsko kompromitiranih odraslih bolnikih, - supresijo ponovitev genitalnega herpesa pri imunsko kompetentnih odraslih bolnikih in mladostnikih ter imunsko kompromitiranih odraslih bolnikih,
English: In organ transplant patients receiving high doses (8000 mg daily) of Valtrex for CMV prophylaxis, neurological reactions occurred more frequently compared with lower doses used for other indications.
Slovenian: Pri prejemnikih presajenih organov, ki so dobivali velike odmerke (8.000 mg na dan) zdravila Valtrex za profilakso CMV, so bili nevrološki učinki pogostejši kot med uporabo manjših odmerkov za druge indikacije.
English: Many of the reported cases involved renally impaired and elderly patients receiving repeated overdoses, due to lack of appropriate dosage reduction.
Slovenian: V številnih opisanih primerih je šlo za bolnike z okvaro ledvic ali za starejše bolnike, ki so dobili več prevelikih odmerkov, ker jim odmerkov niso ustrezno zmanjšali.
English: If you forget to take Valtrex
Slovenian: Če ste pozabili vzeti zdravilo Valtrex
English: • feeling confused
Slovenian: • občutek zmedenosti,
English: The CHMP endorsed the following wording for the treatment of herpes simplex virus: “Valtrex is indicated
Slovenian: CHMP je potrdil naslednje besedilo za zdravljenje okužb z virusom herpes simpleks: „Zdravilo Valtrex je indicirano
English: As requested, the MAH conducted a review of available information since closure of the Pregnancy Registry.
Slovenian: Imetnik dovoljenja za promet z zdravilom je bil naprošen, da opravi pregled razpoložljivih podatkov od zaprtja registra nosečnosti, kar je tudi storil.
English: Use in patients with renal impairment and in elderly patients Aciclovir is eliminated by renal clearance, therefore the dose of valaciclovir must be reduced in patients with renal impairment (see section 4.2).
Slovenian: Uporaba pri bolnikih z okvaro ledvic in pri starejših bolnikih Aciklovir se odstrani skozi ledvice, zato je treba bolnikom z okvaro ledvic odmerek valaciklovirja zmanjšati (glejte poglavje 4.2).
English: The results of Study 123-031 showed a significant difference in time to development of CMV antigenemia and similar delays of acute rejection and fewer opportunistic or other herpes infections in favour of VACV.
Slovenian: Rezultati študije 123-031 so pokazali pomembno razliko v času do pojava antigenemije CMV in podobne zakasnitve akutne zavrnitve ter manj oportunističnih in drugih herpesvirusnih okužb v korist VACV.
English: Data on the efficacy of valaciclovir from transplant patients (~200) at high risk of CMV disease (e.g. donor CMV-positive/recipient CMV negative or use of anti-thymocyte globulin induction therapy) indicate that valaciclovir should only be used in these patients when safety concerns preclude the use of valganciclovir or ganciclovir.
Slovenian: Podatki o učinkovitosti valaciklovirja pri bolnikih (~200) s presajenimi organi in velikim tveganjem bolezni CMV (npr. CMV-pozitiven dajalec/CMV-negativen prejemnik ali uporaba indukcijskega zdravljenja z antitimocitnim imunoglobulinom) kažejo, da naj bi valaciklovir pri teh bolnikih uporabljali le, če zadržki glede varnosti preprečujejo uporabo valganciklovirja ali ganciklovirja.
English: Magnesium stearate Colloidal silicon dioxide
Slovenian: Magnezijev stearat Koloidni silicijev dioksid
English: • For the first infection you should take Valtrex for five days or for up to ten days if your doctor tells you to. For recurrent infection the duration of treatment is normally 3-5 days.
Slovenian: • Za prvo okužbo morate zdravilo Valtrex jemati pet dni ali do deset dni, če vam tako naroči zdravnik.
English: In patients with end-stage renal disease, the average elimination half-life of aciclovir after valaciclovir administration is approximately 14 hours, compared with about 3 hours for normal renal function (see section 4.2).
Slovenian: Pri bolnikih s končno odpovedjo ledvic je povprečen eliminacijski razpolovni čas aciklovirja po uporabi valaciklovirja približno 14 ur, v primerjavi s približno 3 urami v primeru normalnega delovanja ledvic (glejte poglavje 4.2).
English: Intratubular precipitation of aciclovir crystals in the kidney has also been reported.
Slovenian: Opisana je bila tudi intratubularna precipitacija kristalov aciklovirja v ledvicah.
English: Each tablet contains 250 mg, 500 mg or 1000 mg of valaciclovir (as valaciclovir hydrochloride).
Slovenian: Ena tableta vsebuje 250 mg, 500 mg ali 1000 mg valaciklovirja (v obliki valaciklovirjevega klorida).
English: Always tell your doctor or pharmacist about other medicines if you are taking Valtrex for treatment of shingles or after having an organ transplant.
Slovenian: Zdravniku ali farmacevtu morate vedno povedati za svoja druga zdravila, če zdravilo Valtrex jemljete za zdravljenje pasovca ali po presaditvi organa.
English: Ataxia, dysarthria, convulsions, encephalopathy, coma, psychotic symptoms.
Slovenian: ataksija, dizartrija, konvulzije, encefalopatija, koma, psihotični simptomi
English: 250 mg tablets, 1000 mg tablets Two years
Slovenian: 250 mg tablete, 1000 mg tablete Dve leti.
English: Patients with complicated herpes zoster, i.e. those with visceral involvement, disseminated zoster, motor neuropathies, encephalitis and cerebrovascular complications should be treated with intravenous antiviral therapy.
Slovenian: Bolnike, ki imajo zapleten herpes zoster, tj. takšnega z visceralno zajetostjo, diseminiran zoster, motorične nevropatije, encefalitis ali cerebrovaskularne zaplete, je treba zdraviti z intravenskimi protivirusnimi zdravili.
English: Estimates for total area under the acyclovir concentrationtime curve (AUC) are also considered.
Slovenian: Upoštevali so tudi ocene za skupno površino pod krivuljo koncentracije aciklovirja v odvisnosti od časa (AUC).
English: The Lowance study demonstrated that prophylactic treatment with valaciclovir is a safe and effective way to prevent CMV disease after renal transplantation.
Slovenian: V Lowancevi študiji so dokazali, da je profilaktično zdravljenje z valaciklovirjem varen in učinkovit način preprečevanja bolezni CMV po presaditvi ledvic.
English: The CHMP endorsed the proposal from the MAH considering it in line with currently applicable guidelines and accurately reflects data available.
Slovenian: CHMP je potrdil predlog imetnika dovoljenja za promet z zdravilom, ker je v skladu s trenutnimi priporočili in ker točno odraža razpoložljive podatke.
English: HSV resistance to aciclovir, the active metabolite of valaciclovir, as determined by plaque reduction assay has been determined to be less than 1% in immunocompetent subjects and approximately 5-6% in immunocompromised subjects.
Slovenian: Odpornost virusov HSV proti aciklovirju, aktivnemu presnovku valaciklovirja, kakor je bila določena s testom zmanjšanja plakov, je manj kot 1 % pri imunsko kompetentnih osebah in približno 5-6 % pri imunsko kompromitiranih osebah.
English: Aciclovir is a purine (guanine) nucleoside analogue.
Slovenian: Aciklovir je nukleozidni analog purina (gvanina).
English: These studies showed that valaciclovir was superior to placebo and/or as effective as aciclovir in reducing episode duration, viral shedding and lesion healing time.
Slovenian: V teh študijah so dokazali, da je valaciklovir boljši od placeba in/ali enako učinkovit kot aciklovir pri skrajšanju trajanja epizod, obdobja izločanja virusa in časa do zacelitve lezij.
English: The MAH, in order to prove the safety and efficacy of valaciclovir for the treatment of HSV, evaluated the product in a clinical development programme of six studies focusing on genital herpes (HSV-2) infection.
Slovenian: Imetnik dovoljenja za promet z zdravilom je za dokaz varnosti in učinkovitosti valaciklovirja za zdravljenje HSV vrednotil zdravilo v kliničnem razvojnem programu iz šestih študij, ki so bile osredotočene na genitalni herpes (HSV-2).
English: There have been reports of renal insufficiency, microangiopathic haemolytic anaemia and thrombocytopenia (sometimes in combination) in severely immunocompromised adult patients, particularly those with advanced HIV disease, receiving high doses (8000 mg daily) of valaciclovir for prolonged periods in clinical trials.
Slovenian: Opisani so primeri insuficience ledvic, mikroangiopatične hemolitične anemije in trombocitopenije (včasih v kombinaciji) pri imunsko zelo oslabelih bolnikih, zlasti bolnikih z napredovalo boleznijo HIV, ki so v kliničnih raziskavah dolgo časa dobivali velike odmerke (8.000 mg na dan) valaciklovirja.
English: Denmark GlaxoSmithKline Pharma A/S, Nykaer 68
Slovenian: GlaxoSmithKline Pharma A/S, Nykaer 68
English: The CHMP asked for the rationale behind the proposed doses in herpes labialis due to a concern that a dose reduction already at CLcrea 49 ml/min might possibly lead to underexposure.
Slovenian: CHMP je prosil za podlago za predlagane odmerke za labialni herpes zaradi zadržka, da zmanjšanje odmerka že pri ravni CLcrea 49 ml/min morda lahko povzroči premajhno izpostavljenost.
English: The CHMP endorses the following wording: “Valtrex is indicated for the prophylaxis of CMV infection and disease following solid organ transplantation in adults and adolescents”
Slovenian: CHMP je potrdil naslednje besedilo: „Zdravilo Valtrex je indicirano za profilakso okužbe s CMV in bolezni CMV po presaditvi trdnega organa pri odraslih bolnikih in mladostnikih.“
English: Valaciclovir achieves high bioavailability of aciclovir allowing less frequent dosing.
Slovenian: Valaciklovir zagotovi veliko biološko dostopnost aciklovirja, kar omogoči redkejše odmerjanje.
English: With a maternal valaciclovir dosage of 500 mg twice daily, this level would expose a nursing infant to a daily oral aciclovir dosage of about 0.61 mg/kg/day.
Slovenian: Med uporabo 500 mg dvakrat na dan pri materi bi bil dojenček ob tej ravni izpostavljen dnevnemu odmerku aciklovirja približno 0,61 mg/kg/dan.
English: The elimination of aciclovir is correlated to renal function, and exposure to aciclovir will increase with increased renal impairment.
Slovenian: Odstranjevanje aciklovirja je povezano z delovanjem ledvic in z naraščajočo okvaro ledvic se izpostavljenost aciklovirju poveča.
English: Following 1000 mg valaciclovir, cimetidine and probenecid reduce aciclovir renal clearance and increase the AUC of aciclovir by about 25% and 45%, respectively, by inhibition of the active renal secretion of aciclovir.
Slovenian: Po odmerku 1.000 mg valaciklovirja cimetidin in probenecid zmanjšata ledvični očistek aciklovirja za 25 % in povečata njegovo AUC za 45 %, ker zavreta aktivno ledvično sekrecijo aciklovirja.
English: For ARs identified from postmarketing experience, but not observed in clinical trials, the most conservative value of point estimate (“rule of three”) has been used to assign the AR frequency category.
Slovenian: Za neželene učinke, ki so bili ugotovljeni med postmarketinško uporabo, niso pa bili zabeleženi v kliničnih raziskavah, je bila za dodelitev kategorije pogostnosti neželenega učinka uporabljena najbolj konzervativna vrednost točkovne ocene ("pravilo treh").
English: • Treatment and suppression of recurrent ocular HSV infections (see section 4.4)
Slovenian: • za zdravljenje in supresijo ponovitev očesnih okužb s HSV (glejte poglavje 4.4).
English: The possibility of renal impairment in the elderly must be considered and the dose should be adjusted accordingly (see Renal impairment below).
Slovenian: Pri starejših osebah je treba upoštevati možnost okvare ledvic in odmerek ustrezno prilagoditi (glej Okvara ledvic, spodaj).